Viewing Study NCT00961532


Ignite Creation Date: 2025-12-24 @ 9:48 PM
Ignite Modification Date: 2025-12-31 @ 9:22 AM
Study NCT ID: NCT00961532
Status: COMPLETED
Last Update Posted: 2014-08-28
First Post: 2009-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
Sponsor: Northwestern University
Organization:

Study Overview

Official Title: Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept
Status: COMPLETED
Status Verified Date: 2014-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: IMPACT
Brief Summary: The investigators intend to show that DDAVP improves platelet activity from baseline to 60 minutes after treatment start.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: